Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti‐tumour T‐cell activation – IRE ‐ IMMUNO study
BJU International · 2025
DOI: 10.1111/bju.16496 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJU International, 2025. Verfasst von Bart Geboers und 18 weiteren Autor:innen. Beteiligte Einrichtung: Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Electroporation, Prostatectomy, T-Lymphocytes. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cancer Institute NSW Grant, Paul Ramsay Foundation, St Vincent's Prostate Cancer Research Centre.
Abstract (Originalsprache)
Objectives To prospectively compare systemic anti‐tumour immune responses induced by irreversible electroporation (IRE) and robot‐assisted radical prostatectomy (RARP) in patients with localised intermediate‐risk prostate cancer (PCa). Patients and Methods Between February 2021 and June 2022, before and after treatment (at 5, 14 and 30 days) peripheral blood samples of 30 patients with localised PCa were prospectively collected. Patient inclusion criteria were: International Society of Urological Pathologists Grade 2–3, clinical cancer stage ≤T2c, prostate‐specific antigen level
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, New South Wales, Australia.
- St. Vincent's Prostate Cancer Research Centre, Sydney, New South Wales, Australia.
- Department of Urology, St. Vincent's Private Clinic, Sydney, New South Wales, Australia.
- Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, The Netherlands.
- Cancer Centre Amsterdam, Amsterdam, The Netherlands.
- Department of Urology, St. Antonius Hospital, Utrecht, The Netherlands.
ORCID-Profile: Bart Geboers, Matthijs J Scheltema, Paul Doan, James E Thompson, Phillip D Stricker
Förderung
- Cancer Institute NSW Grant
- Paul Ramsay Foundation
- St Vincent's Prostate Cancer Research Centre
- Angio Dynamics
Zitieren
APA
Geboers, B., Scheltema, M. J., Jung, J., Bakker, J., Timmer, F. E. F., Cerutti, X., Katelaris, A., Doan, P., Gondoputro, W., Blazevski, A., Agrawal, S., Matthews, J., Haynes, A. M., Robertson, T., Thompson, J. E., Meijerink, M. R., Clark, S. J., de Gruijl, T. D., & Stricker, P. D. (2025). Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti‐tumour T‐cell activation – IRE ‐ IMMUNO study. BJU International. https://doi.org/10.1111/bju.16496
Vancouver
Geboers B, Scheltema MJ, Jung J, Bakker J, Timmer FEF, Cerutti X, et al. Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti‐tumour T‐cell activation – IRE ‐ IMMUNO study. BJU International. 2025. doi:10.1111/bju.16496
BibTeX
@article{Geboers2025,
author = {Geboers, Bart and Scheltema, Matthijs J and Jung, Jason and Bakker, Joyce and Timmer, Florentine E F and Cerutti, Xanthe and Katelaris, Athos and Doan, Paul and Gondoputro, William and Blazevski, Alexandar and Agrawal, Shikha and Matthews, Jayne and Haynes, Anne-Maree and Robertson, Tim and Thompson, James E and Meijerink, Martijn R and Clark, Susan J and de Gruijl, Tanja D and Stricker, Phillip D},
title = {Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti‐tumour T‐cell activation – IRE ‐ IMMUNO study},
journal = {BJU International},
year = {2025},
doi = {10.1111/bju.16496}
}
EUVIMED